These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 22093941)

  • 1. Method comparison of dipeptidyl peptidase IV activity assays and their application in biological samples containing reversible inhibitors.
    Matheeussen V; Lambeir AM; Jungraithmayr W; Gomez N; Mc Entee K; Van der Veken P; Scharpé S; De Meester I
    Clin Chim Acta; 2012 Feb; 413(3-4):456-62. PubMed ID: 22093941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.
    dos Santos L; Salles TA; Arruda-Junior DF; Campos LC; Pereira AC; Barreto AL; Antonio EL; Mansur AJ; Tucci PJ; Krieger JE; Girardi AC
    Circ Heart Fail; 2013 Sep; 6(5):1029-38. PubMed ID: 23894014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A time-resolved fluorescence probe for dipeptidyl peptidase 4 and its application in inhibitor screening.
    Kawaguchi M; Okabe T; Terai T; Hanaoka K; Kojima H; Minegishi I; Nagano T
    Chemistry; 2010 Dec; 16(45):13479-86. PubMed ID: 20938933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and spatial heterogeneity of dipeptidyl peptidases in endothelial cells of conduct vessels and capillaries.
    Matheeussen V; Baerts L; De Meyer G; De Keulenaer G; Van der Veken P; Augustyns K; Dubois V; Scharpé S; De Meester I
    Biol Chem; 2011 Mar; 392(3):189-98. PubMed ID: 21194356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dipeptidyl peptidase IV in the hypothalamus and hippocampus of monosodium glutamate obese and food-deprived rats.
    Alponti RF; Frezzatti R; Barone JM; Alegre Vde S; Silveira PF
    Metabolism; 2011 Feb; 60(2):234-42. PubMed ID: 20153005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RBx-0597, a potent, selective and slow-binding inhibitor of dipeptidyl peptidase-IV for the treatment of type 2 diabetes.
    Singh S; Roy S; Sethi S; Benjamin B; Sundaram S; Khanna V; Kandalkar SR; Pal C; Kant R; Patra AK; Rayasam G; Mittra S; Saini KS; Paliwal J; Chugh A; Ahmed S; Sattigeri J; Cliff I; Ray A; Bansal VS; Bhatnagar PK; Davis JA
    Eur J Pharmacol; 2011 Feb; 652(1-3):157-63. PubMed ID: 20540938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
    Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
    Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dipeptidyl peptidase IV inhibition downregulates Na+ - H+ exchanger NHE3 in rat renal proximal tubule.
    Girardi AC; Fukuda LE; Rossoni LV; Malnic G; Rebouças NA
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F414-22. PubMed ID: 18077600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD26/dipeptidyl peptidase IV: a comparative study of healthy persons and kidney transplant recipients before and early after transplantation.
    Leicht S; Shipkova M; Klett C; Gert H; Altrock E; Wilhelm J; Bolley R; Wollmeyer J; Ender A; Luz B; Olbricht C; Wieland E
    Clin Biochem; 2013 Oct; 46(15):1383-8. PubMed ID: 23608353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (2S,4S)-4-Fluoro-1-{[(2-hydroxy-1,1-dimethylethyl)amino]acetyl}-pyrrolidine-2-carbonitrile monobenzenesulfonate (TS-021) is a selective and reversible dipeptidyl peptidase IV inhibitor.
    Tajima A; Yamamoto K; Kozakai A; Okumura-Kitajima L; Mita Y; Kitano K; Jingu S; Nakaike S
    Eur J Pharmacol; 2011 Mar; 655(1-3):99-107. PubMed ID: 21262219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation and characterization of peptides with dipeptidyl peptidase IV (DPPIV) inhibitory activity from natto using DPPIV from Aspergillus oryzae.
    Sato K; Miyasaka S; Tsuji A; Tachi H
    Food Chem; 2018 Sep; 261():51-56. PubMed ID: 29739605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dipeptidyl peptidase-4 inhibitor with β-amino amide scaffold: synthesis, SAR and biological evaluation.
    Kim HJ; Kwak WY; Min JP; Sung SY; Kim HD; Kim MK; Kim HS; Park KJ; Son MH; Kim SH; Lee BJ
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5545-9. PubMed ID: 22850208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase IV reduces trophoblast invasion by inhibiting the activity of MMPs.
    Li Y; Li Z; Zhang J
    Int J Dev Biol; 2014; 58(5):349-53. PubMed ID: 25354455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pro-soft Val-boroPro: a strategy for enhancing in vivo performance of boronic acid inhibitors of serine proteases.
    Poplawski SE; Lai JH; Sanford DG; Sudmeier JL; Wu W; Bachovchin WW
    J Med Chem; 2011 Apr; 54(7):2022-8. PubMed ID: 21388136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peptide truncation by dipeptidyl peptidase IV: a new pathway for drug discovery?
    Scharpé S; De Meester I
    Verh K Acad Geneeskd Belg; 2001; 63(1):5-32; discussion 32-3. PubMed ID: 11284388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of the dipeptidyl peptidase IV (DPPIV/CD26) based prodrug approach to different amine-containing drugs.
    Diez-Torrubia A; García-Aparicio C; Cabrera S; De Meester I; Balzarini J; Camarasa MJ; Velázquez S
    J Med Chem; 2010 Jan; 53(2):559-72. PubMed ID: 20000418
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties.
    Shibuya-Saruta H; Kasahara Y; Hashimoto Y
    J Clin Lab Anal; 1996; 10(6):435-40. PubMed ID: 8951616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A possible role for CD26/DPPIV enzyme activity in the regulation of psoriatic pruritus.
    Komiya E; Hatano R; Otsuka H; Itoh T; Yamazaki H; Yamada T; Dang NH; Tominaga M; Suga Y; Kimura U; Takamori K; Morimoto C; Ohnuma K
    J Dermatol Sci; 2017 Jun; 86(3):212-221. PubMed ID: 28365081
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The highly potent and selective dipeptidyl peptidase IV inhibitors bearing a thienopyrimidine scaffold effectively treat type 2 diabetes.
    Deng J; Peng L; Zhang G; Lan X; Li C; Chen F; Zhou Y; Lin Z; Chen L; Dai R; Xu H; Yang L; Zhang X; Hu W
    Eur J Med Chem; 2011 Jan; 46(1):71-6. PubMed ID: 21106276
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dipeptidyl peptidase IV deficiency increases susceptibility to angiotensin-converting enzyme inhibitor-induced peritracheal edema.
    Byrd JB; Shreevatsa A; Putlur P; Foretia D; McAlexander L; Sinha T; Does MD; Brown NJ
    J Allergy Clin Immunol; 2007 Aug; 120(2):403-8. PubMed ID: 17531305
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.